Chinese Pharmaceutical

Data & statistics on Chinese Pharmaceutical – 88 results

China ethylene oxide demand breakdown

www.quamnet.com/media/IPO/2198_prospectus_e.pdf

The demand for ethylene oxide in China is closely correlated ...
in China. The remaining 40% of the total consumption was occupied by the production ...
for ethylene oxide in China in May 2010: Non-ionic surfactants (60%) Others (Note) (16

Sep 2010 | www.quamnet.com

Original Url: http://www.quamnet.com/media/IPO/2198_prospectus_e.pdf

Growth of Generics

www.quamnet.com/media/IPO/LTN20101015019.pdf

pharmaceutical market. Most domestic pharmaceutical companies in the PRC manufacture and sell ...
of the PRC pharmaceutical market, in terms of hospital purchases, and from 2005 to 2009 ...
of the growth in the PRC pharmaceutical market will continue to come from branded generic

Jan 2009 | www.quamnet.com

Original Url: http://www.quamnet.com/media/IPO/LTN20101015019.pdf

Metabolic regulation and alimentary system (12.5%)

www.quamnet.com/media/IPO/LTN20110408053.pdf

4% of the PRC pharmaceutical market respectively. Below is a graph setting out the breakdown of the main therapeutic categories for the Chinese pharmaceutical market in 2008: Source ...
and marketing, or promotion, practices in the Chinese pharmaceutical market have become more ...
china

Apr 2011 | www.quamnet.com

Original Url: http://www.quamnet.com/media/IPO/LTN20110408053.pdf

CAGR, 2009-2014: 22.5%

www.quamnet.com/media/IPO/LTN20101015019.pdf

and data on the PRC pharmaceutical industry in relation to the Global Offering ...
drug market in the PRC from 2009 to 2014. Hospital Purchases (RMB millions) CNS ...
intelligence provider in pharmaceutical and healthcare industries and has provided data

Jan 2014 | www.quamnet.com

Original Url: http://www.quamnet.com/media/IPO/LTN20101015019.pdf

FINANCIAL INFORMATION (NOTE)

www.quamnet.com/media/IPO/1110_prospectus_E.pdf

The Group’s other revenue primarily consists of interest income on financial assets not at fair value through profit or loss, rental income and commission income from Supplier, which represents income from Mentholatum (China) Pharmaceuticals Company ...
china

Nov 2010 | www.quamnet.com

Original Url: http://www.quamnet.com/media/IPO/1110_prospectus_E.pdf

Measures for the Certification of Good Supply Practice ).............

www.quamnet.com/media/IPO/IPO-20131024-E.pdf

INDUSTRY REGULATORY FRAMEWORK Our operations within the PRC are subject to regulatory controls governing pharmaceutical products and medical devices. The following are the major PRC applicable laws and regulations that our operations are subject ...
Measures for the Administration of Pharmaceutical Supply Permits ( ) ......... SFDA 4 February 2004 1 April 2004 Measures for the Administration of Licences ...
9 August 2004 ( Good Supply Practice for Pharmaceutical Products

Jan 2013 | www.quamnet.com

Original Url: http://www.quamnet.com/media/IPO/IPO-20131024-E.pdf

Type of registration certificate

www.quamnet.com/media/IPO/1110_prospectus_E.pdf

certificate shall expire on 8 October 2015. The Pharmaceutical Product Registration ...
of the Pharmaceutical Product Registration Certificate has been submitted before the expiry of each of their certificates. As the relevant PRC authorities requested SZ Kingworld to submit extra ...
Seirogan 21 February 2015 Flying Eagle Wood Lok Medicated Oil Pharmaceutical Product Registration Certificate 5 December 2010 Pharmaceutical Product Registration Certificate Min Tong Chisionhon Granules 11 April 2010 Pharmaceutical Product Registration

Jan 2015 | www.quamnet.com

Original Url: http://www.quamnet.com/media/IPO/1110_prospectus_E.pdf

Total numbers of class-three and class-two hospitals are based on data as of 2009 according to the MOH.

www.quamnet.com/media/IPO/LTN20110408053.pdf

and cardiovascular products. We are generally the sole promoter in China for our key pharmaceutical promotion and sales products. Our pharmaceutical products portfolio ...
are originator branded generics, which are pharmaceutical products that no longer enjoy ...
2009 Market 2008 Market 2007 Market Share in China Share in China Share in China (Ranking) (Ranking) (Ranking) Name Fortum (GSK) . . . . . . . . . . . . . . . . . . . . . . . . . (1) (1) (1) Cefobid (Pfizer) . . . . . . . . . . . . . . . . . . . . . . . . . (1) (1) (1) Unasyn

Jan 2009 | www.quamnet.com

Original Url: http://www.quamnet.com/media/IPO/LTN20110408053.pdf

COMPETITIVE LANDSCAPE WITHIN OUR INDUSTRY

www.quamnet.com/media/IPO/IPO-20131024-E.pdf

0% of the total imported pharmaceutical product and medical device market in China in 2012, according ...
of pharmaceutical marketing, promotion and channel management services in China for the years indicated: Market share Key industry players China Medical System ...
pharmaceutical products grew from RMB26.8 billion in 2008 to RMB60.3 billion in 2012

Jan 2012 | www.quamnet.com

Original Url: http://www.quamnet.com/media/IPO/IPO-20131024-E.pdf

Total Year - Over - Year Growth

www.quamnet.com/media/IPO/LTN20110408053.pdf

The pharmaceutical market has continued to grow in China for the past several ...
that the majority of pharmaceutical expenditure in China involves the sale of prescription ...
in China reached US$46.8 billion (approximately RMB319.3 billion) in 2009

Jan 2009 | www.quamnet.com

Original Url: http://www.quamnet.com/media/IPO/LTN20110408053.pdf